Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.2%

1 terminated out of 46 trials

Success Rate

94.4%

+7.9% vs benchmark

Late-Stage Pipeline

28%

13 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed with results

Key Signals

94% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (12)
P 1 (2)
P 2 (11)
P 3 (2)
P 4 (11)

Trial Status

Completed17
Unknown14
Recruiting11
Not Yet Recruiting2
Terminated1
Active Not Recruiting1

Trial Success Rate

94.4%

Benchmark: 86.6%

Based on 17 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT07788378Completed

Metformin in Elderly Patients With Type 2 Diabetes and Muscle Strength, Muscle Mass, and Physical Function: Positive or Negative Correlation?

NCT05120505Phase 4Completed

Metformin in Children With Fragile X Syndrome

NCT06638671Phase 4Completed

Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity

NCT05900284Phase 2Completed

Safety and Feasibility of Metformin for Sepsis Induced AKI

NCT07131384Not ApplicableRecruiting

Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes

NCT05013112Not ApplicableCompleted

Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)

NCT07436182Phase 4Not Yet Recruiting

Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy

NCT02915198Phase 4Recruiting

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

NCT05532813Phase 3Recruiting

Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)

NCT07193069Recruiting

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

NCT05680805Phase 4Active Not Recruiting

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

NCT05929495Phase 2Recruiting

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

NCT06325969Completed

PCOS Patients' Immune Alterations

NCT06459310Phase 2RecruitingPrimary

Pilot Study on Evaluating the Geroprotective Effect of Metformin

NCT04947020Completed

DataBase for Analysis of Rectal Cancer Oncological Results

NCT06353061Phase 2Recruiting

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

NCT06125587Phase 2Completed

Chiglitazar/Metformin in Non-obese Women With PCOS

NCT06717087Not ApplicableNot Yet Recruiting

Study of Acupuncture to Control Weight and Improve Pregnancy Rates in Overweight/Obese PCOS Patients

NCT03618472Not ApplicableCompletedPrimary

Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells

NCT06603480Not ApplicableCompleted

Effects of Exercise and Metformin on Methylglyoxal Levels in Prediabetic Individuals

Scroll to load more

Research Network

Activity Timeline